NASDAQ$ARAY
Accuray Inc · Q3 2023 earnings
Q3 2023 earnings · · Investor relations
Briefing
Accuray delivered record quarterly revenue and unit volume in Q3 and reiterated fiscal year guidance.
Accuray reported a strong third quarter with a 22.8% increase in net revenue to $118.1 million and a GAAP net income of $0.6 million, driven by growing global demand for its radiotherapy solutions. The company shipped a record 30 systems and achieved its 1,000+ installed system milestone.
- Net revenue increased 22.8 percent to $118.1 million compared to the same period in the prior fiscal year.
- GAAP net income was $0.6 million, compared to a GAAP net loss of $1.0 million in the same period in the prior fiscal year.
- Adjusted EBITDA increased 53.5 percent to $8.3 million compared to the same period in the prior fiscal year.
- Shipped 30 systems, a new quarterly record, representing a 67 percent increase compared to the prior year period.
Headline financials
Revenue & EPS history
Accuray · Revenue · Quarterly
$118M
Revenue by segment
Accuray · $118M total across 2 segments · Q3 2023
- Products Revenue$62.8M—53.2%
- Services Revenue$55.2M—46.8%
Forward guidance
Accuray reaffirmed its fiscal year 2023 guidance, expecting total revenue in the range of $447.0 million to $455.0 million and adjusted EBITDA in the range of $26.0 million to $30.0 million.
Tailwinds
- Total revenue is expected in the range of $447.0 million to $455.0 million, representing a year-over-year growth at the midpoint of the range of 5 percent.
- Adjusted EBITDA is expected in the range of $26.0 million to $30.0 million.
Headwinds
- Actual results could differ materially depending on market conditions.
- The impact of the current global economic environment and the Covid-19 pandemic could impact results.
- Supply chain disruption could negatively impact results.
- The company's ability to navigate macroeconomic challenges could impact results.
- Foreign exchange challenges could negatively impact results.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q3 2023
-0.1%
Avg return
Earnings day
+0.4%
Avg return
5 days after
-0.8%
Avg return
30 days after
47%
30 / 64 earnings
Positive
+49.7%
Q4 2024
Best reaction
-39.6%
Q3 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | -39.6% | -35.4% | — | |
| Q2 2026 | -21.1% | -27.6% | -35.5% | |
| Q1 2026 | -15.9% | -19.3% | -31.7% | |
| Q3 2025 | -12.9% | -16.1% | -1.3% | |
| Q2 2025 | +8.0% | -8.0% | -25.3% | |
| Q1 2025 | +8.9% | +3.1% | +4.7% | |
| Q4 2024 | +49.7% | +62.1% | +51.0% | |
| Q3 2024 | -27.7% | -16.0% | -16.9% | |
| Q2 2024 | -5.2% | -11.9% | -3.3% | |
| Q1 2024 | -0.7% | -7.8% | -1.1% | |
| Q4 2023 | -23.2% | -23.2% | -35.9% | |
| Q3 2023 | +14.4% | +24.9% | +31.0% | |
| Q2 2023 | +14.3% | +18.3% | +19.4% | |
| Q1 2023 | +1.5% | +4.5% | +2.5% | |
| Q4 2022 | +27.5% | +43.5% | +15.0% | |
| Q3 2022 | -10.2% | -15.2% | -31.4% | |
| Q2 2022 | -15.9% | -11.0% | -13.2% | |
| Q1 2022 | +9.7% | +1.9% | -9.3% | |
| Q4 2021 | -3.7% | -10.7% | -9.2% | |
| Q3 2021 | -11.1% | -14.7% | -22.9% | |
| Q2 2021 | +4.1% | -4.3% | -3.3% | |
| Q1 2021 | +2.5% | +16.9% | +51.4% | |
| Q4 2020 | -6.6% | -10.6% | -17.2% | |
| Q3 2020 | +26.3% | +21.1% | +10.0% | |
| Q2 2020 | +13.4% | +3.2% | -21.2% | |
| Q1 2020 | -4.8% | -11.4% | +5.5% | |
| Q4 2019 | -15.5% | -16.1% | -9.6% | |
| Q3 2019 | +1.7% | +4.3% | -5.5% | |
| Q2 2019 | +14.2% | +15.5% | +36.2% | |
| Q1 2019 | +32.8% | +40.5% | +20.1% | |
| Q4 2018 | +11.5% | +14.9% | +9.2% | |
| Q3 2018 | -15.3% | -8.9% | -10.9% | |
| Q2 2018 | +8.7% | +9.7% | -1.9% | |
| Q1 2018 | +3.5% | +14.1% | +24.7% | |
| Q4 2017 | +5.1% | +5.1% | +14.1% | |
| Q3 2017 | -5.2% | -12.5% | -13.5% | |
| Q2 2017 | +1.8% | +1.8% | -2.7% | |
| Q1 2017 | -5.7% | -7.5% | +0.0% | |
| Q4 2016 | -8.8% | -3.1% | -0.5% | |
| Q3 2016 | -7.1% | — | — | |
| Q2 2016 | -12.2% | — | — | |
| Q1 2016 | +6.3% | — | — | |
| Q4 2015 | +10.2% | — | — | |
| Q3 2015 | -22.4% | — | — | |
| Q2 2015 | +6.0% | — | — | |
| Q1 2015 | -15.9% | — | — | |
| Q4 2014 | +2.6% | — | — | |
| Q3 2014 | -8.9% | — | — | |
| Q2 2014 | +19.4% | — | — | |
| Q1 2014 | +11.4% | — | — | |
| Q4 2013 | +5.1% | — | — | |
| Q3 2013 | +12.2% | — | — | |
| Q2 2013 | -12.4% | — | — | |
| Q1 2013 | +0.0% | — | — | |
| Q4 2010 | -2.8% | — | — | |
| Q4 2012 | -9.3% | — | — | |
| Q3 2011 | -9.4% | — | — | |
| Q3 2012 | -9.4% | — | — | |
| Q2 2012 | +16.6% | — | — | |
| Q2 2011 | +16.6% | — | — | |
| Q4 2011 | -3.5% | — | — | |
| Q1 2011 | -3.5% | — | — | |
| Q1 2012 | -3.5% | — | — | |
| Q3 2010 | -0.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro